Catalyst Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Catalyst Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Catalyst Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Catalyst Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Catalyst Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Catalyst Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Richard J. Daly
President; Chief Executive Officer; Director Executive BoardMr. Richard J. Daly has been the Chief Executive Officer, Director, and President of the company since January 2024. Prior to this, he served as the President of CARsgen Therapeutics Corporation and Chief Operating Officer at Beyond Springs Inc. Previously, he served as the Chief Executive Officer, President, and Chairman of Neuralstem Inc.
Michael W. Kalb
Executive Vice President; Chief Financial Officer; Treasurer Senior ManagementMr. Michael W. Kalb has been the Executive Vice President, Chief Financial Officer, and Treasurer of the company since January 2024. Prior to this, he served as the Chief Financial Officer of Impel Pharmaceuticals. Previously, he served as the Executive Vice President and Chief Financial Officer of CinCor Pharma Inc. Mr. Kalb also served as the Senior Vice President and Chief Financial Officer of Amarin Corporation Plc.
Steven R. Miller, Ph.D.
Executive Vice President; Chief Operating Officer; Chief Scientific Officer Senior ManagementMr. Steven R. Miller has been the Executive Vice President, Chief Operating Officer, and Chief Scientific Officer of the company since January 2024. Prior to this, he served as the Executive Director of Research and Development Operations at Watson Pharmaceuticals; and Vice President of Research and Product Development at Royce Laboratories. Dr. Miller also served as an Analytical Chemist for the US Food and Drug Administration and managed medical device development groups at Baxter Diagnostics.
Preethi Sundaram, Ph.D.
Chief Strategy Officer Senior ManagementMs. Preethi Sundaram has been the Chief Strategy Officer of the company since 2022. Prior to this, she served as the Chief Product Development Officer of the company. Previously, she served in various senior leadership positions at Sanofi including Global Clinical Research Director, International Development from 2005-2010, Global Project Head, Multiple Therapeutic Area Programs from 2010 until 2017, Global Head and VP, Medical Operations, Primary Care Business Unit from 2017 until 2020, and since October2020, as Sanofi’s Global Head and VP, Medical Operations, General Medicines Business Unit.
Brian Elsbernd
Chief Legal Officer; Chief Compliance Officer Senior ManagementMr. Brian Elsbernd has been the Chief Compliance Officer and Chief Legal Officer of the company since 2019. Prior to this, he served as the Senior Vice President of Legal and Compliance for the company. Previously, he served as the Senior Director of US Healthcare Compliance at Mallinckrodt Pharmaceuticals. Mr. Elsbernd also served as the Associate at Proskauer Rose LLP, within its Health Care practice group.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer